These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21596927)

  • 1. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.
    Thal DM; Yeow RY; Schoenau C; Huber J; Tesmer JJ
    Mol Pharmacol; 2011 Aug; 80(2):294-303. PubMed ID: 21596927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.
    Tesmer JJ; Tesmer VM; Lodowski DT; Steinhagen H; Huber J
    J Med Chem; 2010 Feb; 53(4):1867-70. PubMed ID: 20128603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the putative G protein-coupled receptor (GPCR) docking site on GPCR kinase 2: insights from intact cell phosphorylation and recruitment assays.
    Beautrait A; Michalski KR; Lopez TS; Mannix KM; McDonald DJ; Cutter AR; Medina CB; Hebert AM; Francis CJ; Bouvier M; Tesmer JJ; Sterne-Marr R
    J Biol Chem; 2014 Sep; 289(36):25262-75. PubMed ID: 25049229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing a structure-based docking approach to develop potent G protein-coupled receptor kinase (GRK) 2 and 5 inhibitors.
    Waldschmidt HV; Bouley R; Kirchhoff PD; Lee P; Tesmer JJG; Larsen SD
    Bioorg Med Chem Lett; 2018 May; 28(9):1507-1515. PubMed ID: 29627263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of inhibitors of the RGS homology domain of GRK2 by docking-based virtual screening.
    Echeverría E; Velez Rueda AJ; Cabrera M; Juritz E; Burghi V; Fabián L; Davio C; Lorenzano Menna P; Fernández NC
    Life Sci; 2019 Dec; 239():116872. PubMed ID: 31525427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
    Waldschmidt HV; Homan KT; Cato MC; Cruz-Rodríguez O; Cannavo A; Wilson MW; Song J; Cheung JY; Koch WJ; Tesmer JJ; Larsen SD
    J Med Chem; 2017 Apr; 60(7):3052-3069. PubMed ID: 28323425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog.
    Homan KT; Wu E; Wilson MW; Singh P; Larsen SD; Tesmer JJ
    Mol Pharmacol; 2014 Feb; 85(2):237-48. PubMed ID: 24220010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation.
    Pao CS; Barker BL; Benovic JL
    Biochemistry; 2009 Aug; 48(30):7325-33. PubMed ID: 19715378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural domains required for Caenorhabditis elegans G protein-coupled receptor kinase 2 (GRK-2) function in vivo.
    Wood JF; Wang J; Benovic JL; Ferkey DM
    J Biol Chem; 2012 Apr; 287(16):12634-44. PubMed ID: 22375004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRK2 activation by receptors: role of the kinase large lobe and carboxyl-terminal tail.
    Sterne-Marr R; Leahey PA; Bresee JE; Dickson HM; Ho W; Ragusa MJ; Donnelly RM; Amie SM; Krywy JA; Brookins-Danz ED; Orakwue SC; Carr MJ; Yoshino-Koh K; Li Q; Tesmer JJ
    Biochemistry; 2009 May; 48(20):4285-93. PubMed ID: 19338266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1.
    Keretsu S; Bhujbal SP; Joo Cho S
    Sci Rep; 2019 Sep; 9(1):13053. PubMed ID: 31506468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for small molecule inhibition of G protein-coupled receptor kinases.
    Homan KT; Tesmer JJ
    ACS Chem Biol; 2015 Jan; 10(1):246-56. PubMed ID: 24984143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Open Question of How GPCRs Interact with GPCR Kinases (GRKs).
    Cato MC; Yen YC; Francis CJ; Elkins KE; Shareef A; Sterne-Marr R; Tesmer JJG
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.
    Bouley R; Waldschmidt HV; Cato MC; Cannavo A; Song J; Cheung JY; Yao XQ; Koch WJ; Larsen SD; Tesmer JJG
    Mol Pharmacol; 2017 Dec; 92(6):707-717. PubMed ID: 29070696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors.
    Waldschmidt HV; Homan KT; Cruz-Rodríguez O; Cato MC; Waninger-Saroni J; Larimore KM; Cannavo A; Song J; Cheung JY; Kirchhoff PD; Koch WJ; Tesmer JJ; Larsen SD
    J Med Chem; 2016 Apr; 59(8):3793-807. PubMed ID: 27050625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives.
    Guccione M; Ettari R; Taliani S; Da Settimo F; Zappalà M; Grasso S
    J Med Chem; 2016 Oct; 59(20):9277-9294. PubMed ID: 27362616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory effects of GRK2 on GPCRs and non-GPCRs and possible use as a drug target (Review).
    Han CC; Ma Y; Li Y; Wang Y; Wei W
    Int J Mol Med; 2016 Oct; 38(4):987-94. PubMed ID: 27573285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A surface of the kinase domain critical for the allosteric activation of G protein-coupled receptor kinases.
    Huang CC; Yoshino-Koh K; Tesmer JJG
    J Biol Chem; 2009 Jun; 284(25):17206-17215. PubMed ID: 19364770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2.
    Carman CV; Parent JL; Day PW; Pronin AN; Sternweis PM; Wedegaertner PB; Gilman AG; Benovic JL; Kozasa T
    J Biol Chem; 1999 Nov; 274(48):34483-92. PubMed ID: 10567430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of G beta gamma and domain interfaces in the activation of G protein-coupled receptor kinase 2.
    Lodowski DT; Barnhill JF; Pyskadlo RM; Ghirlando R; Sterne-Marr R; Tesmer JJ
    Biochemistry; 2005 May; 44(18):6958-70. PubMed ID: 15865441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.